Universitätsklinikum Ulm

Hospital


Location: Ulm, Germany (DE) DE

ISNI: -

ROR: https://ror.org/05emabm63

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Treatment and outcomes of patients in the Brain Metastases in Breast Cancer Network Registry (2018) Witzel I, Laakmann E, Weide R, Neunhoeffer T, Park-Simon TJ, Schmidt M, Fasching P, et al. Journal article Whole blood microRNAs as potential biomarkers in post-operative early breast cancer patients (2018) Alunni-Fabbroni M, Majunke L, Trapp EK, Tzschaschel M, Mahner S, Fasching P, Fehm T, et al. Journal article Update Breast Cancer 2018 (Part 2) - Advanced Breast Cancer, Quality of Life and Prevention (2018) Schneeweiss A, Lux MP, Janni W, Hartkopf AD, Nabieva N, Taran FA, Overkamp F, et al. Journal article Update Breast Cancer 2018 (Part 1) - Primary Breast Cancer and Biomarkers (2018) Taran FA, Schneeweiss A, Lux MP, Janni W, Hartkopf AD, Nabieva N, Overkamp F, et al. Journal article Update Breast Cancer 2018 (Part 4) - Genomics, Individualized Medicine and Immune Therapies - in the Middle of a New Era: Treatment Strategies for Advanced Breast Cancer (2018) Mueller V, Woeckel A, Lux MP, Janni W, Hartkopf AD, Nabieva N, Taran FA, et al. Journal article Update Breast Cancer 2018 (Part 3) - Genomics, Individualized Medicine and Immune Therapies - in the Middle of a New Era: Prevention and Treatment Strategies for Early Breast Cancer (2018) Woeckel A, Lux MP, Janni W, Hartkopf AD, Nabieva N, Taran FA, Overkamp F, et al. Journal article Efficacy and safety of Trifluridin/Tipiracil (FTD/TPI) (Lonsurf (R)) in patients with metastatic colorectal cancer (CRC) in clinical-routine use (2018) Cao J, Wiesweg M, Fuchs M, Stein A, Karthaus M, Lettmaier S, Kretzschmar A, et al. Conference contribution Treatment landscape of advanced breast cancer patients with hormone receptor positive HER2 negative tumors - Data from the German PRAEGNANT breast cancer registry (2018) Hartkopf AD, Huober J, Volz B, Nabieva N, Taran FA, Schwitulla J, Overkamp F, et al. Journal article RECREATE: Treatment reality for mRCCpatients following first line Pazopanib therapy - a retrospective chart review (2018) Hegele A, Von Der Heyde E, Goebell P, Huebner A, Zengerling F, Klier J, Belz H, et al. Conference contribution Impact of disease progression on health-related quality of life in patients with metastatic breast cancer in the PRAEGNANT breast cancer registry (2018) Mueller V, Nabieva N, Häberle L, Taran FA, Hartkopf AD, Volz B, Overkamp F, et al. Journal article